Nath Bio-Genes (India) Ratios

Nath Bio-Genes (India) Ltd Ratios

The Nath Bio-Genes (India) Ltd Ratios page provides a complete fundamental analysis of Nath Bio-Genes (India) Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Nath Bio-Genes (India) Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Nath Bio-Genes (India) Ltd (NSE: NATHBIOGEN, BSE: 537291) is currently trading at ₹146.78, with a market capitalization of ₹2.82B. As a major player in the Process industries sector and Agricultural commodities/Milling industry, Nath Bio-Genes (India) Ltd remains a key stock for fundamental analysis using Nath Bio-Genes (India) Ltd Ratios.

Nath Bio-Genes (India) Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Nath Bio-Genes (India) Ltd P/E ratio currently stands at 7.18, making it one of the most tracked metrics in Nath Bio-Genes (India) Ltd Ratios.

Historically, the Nath Bio-Genes (India) Ltd P/E ratio has shown strong fluctuations:

• 2024: 7.18
• 2023: 8.33
• 2022: 7.69
• 2021: 0
• 2020: 10.24

The decline in Nath Bio-Genes (India) Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Nath Bio-Genes (India) Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.43.

Historical P/B trend:

• 2024: 0.43
• 2023: 0.54
• 2022: 0.47
• 2021: 0.75

Nath Bio-Genes (India) Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Nath Bio-Genes (India) Ltd P/S ratio currently stands at 1.03, an important part of Nath Bio-Genes (India) Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 1.03
• 2023: 1.33
• 2022: 1.15
• 2021: 1.76

A stable or declining Nath Bio-Genes (India) Ltd P/S ratio indicates cautious market sentiment.

Nath Bio-Genes (India) Ltd Price to Cash Flow Ratio (P/CF)

The Nath Bio-Genes (India) Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 25.94.

Historical Nath Bio-Genes (India) Ltd Price to Cash Flow Ratio:

• 2024: 25.94
• 2023: 5.02
• 2022: 9.53
• 2021: 53.85
• 2020: 0

The rising Nath Bio-Genes (India) Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Nath Bio-Genes (India) Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Nath Bio-Genes (India) Ltd EV currently stands at ₹3.11B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 3.11B
• 2023: 3.63B
• 2022: 3.36B
• 2021: 4.94B

Nath Bio-Genes (India) Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Nath Bio-Genes (India) Ltd EV/EBITDA ratio is currently 5.98, a key metric in Nath Bio-Genes (India) Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 5.98
• 2023: 7.13
• 2022: 6.76
• 2021: 12.73

Stable Nath Bio-Genes (India) Ltd EV/EBITDA indicates balanced valuation.

Nath Bio-Genes (India) Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Nath Bio-Genes (India) Ltd D/E ratio is currently 0.19, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.19
• 2023: 0.18
• 2022: 0.18
• 2021: 0.17

Nath Bio-Genes (India) Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Nath Bio-Genes (India) Ltd ROE currently stands at 6.15%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 6.15
• 2023: 6.70
• 2022: 6.28
• 2021: -11.67

Declining ROE indicates pressure on profitability.

Nath Bio-Genes (India) Ltd Ratios Analysis Summary

The Nath Bio-Genes (India) Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Nath Bio-Genes (India) Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Nath Bio-Genes (India) Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.